Current aspects on oral squamous cell carcinoma

Open Dentistry Journal

Volumn 6, Issue 1, 2012, Pages 126-130

  Markopoulos, Anastasios K ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Oral squamous cell carcinoma; Overview

Indexed keywords

EID: 84871034926     PISSN: 18742106     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874210601206010126     Document Type: Article

References (54)

1. Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 2000; 53: 165-72.
2. Siddiqui IA, Farooq MU, Siddiqui RA, Rafi SMT. Role of toluidine blue in early detection of oral cancer. Pak J Med Sci 2006; 22:184-7.
3. Sharma P, Saxena S, Aggarwal P. Trends in the epidemiology of oral squamous cell carcinoma in Western UP: an institutional study. Ind J Dent Res 2010; 21: 316-9.
4. Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 2008; 87: 14-32.
5. Mehrotra R, Yadav S. Oral squamous cell carcinoma: etiology, pathogenesis and prognostic value of genomic alterations. Indian J Cancer 2006; 43: 60-6.
6. Patel SC, Carpenter WR, Tyree S, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 2011; 29(11): 1488-94.
7. Scott SE, Grunfeld EA, Main J, McGurk M. Patient delay in oral cancer: a qualitative study of patients' experiences. Psychooncology 2006; 15: 474-85.
8. Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Cancer Res Ther 2010; 6: 487-91.
9. de FreitasCordeiro-Silva M, Oliveira ZF, de Podestá JR, Gouvea SA, Von Zeidler SV, Louro ID. Methylation analysis of cancerrelated genes in non-neoplastic cells from patients with oral squamous cell carcinoma. Mol Biol Rep 2011; 38(8): 5435-41.
10. Marichalar-Mendia X, Acha-Sagredo A, Rodriguez-Tojo MJ, et al. Alcohol-dehydrogenase (ADH1B) Arg48His polymorphism in Basque country patients with oral and laryngeal cancer: preliminary study. Anticancer Res 2011; 31: 677-80.
11. Warnakulasuriya S, Sutherland G, Scully C. Tobacco, oral cancer and treatment of dependence. Oral Oncol 2005; 41: 244-60.
12. Zygogianni AG, Kyrgias G, Karakitsos P, et al. Oral squamous cell cancer: early detectionand the role of alcohol and smoking. Head Neck Oncol 2011; 3: 2.
13. Ogden GR. Alcohol and oral cancer. Alcohol 2005; 35:169-73.
14. Su CC, Yang HF, Huang SJ, LianIeB. Distinctive features of oral cancerin Changhua County: high incidence, buccal mucosa preponderance, and a close relation to betel quid chewing habit. J Formos Med Assoc 2007; 106: 225-33.
15. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24(10): 450-3.
16. Subapriya R, Thangavelu A, Mathavan B, Ramachandran CR, Nagini S. Assessment of risk factors for oral squamous cell carcinoma in Chidambaram, Southern India: a case-control study. Eur J Cancer Prev 2007; 16: 251-6.
17. Thavarajah R, Rao A, Raman U, Rajasekaran ST, Joshua ERH, Kannan R. Oral lesions of 500 habitual psychoactive substance users in Chennai, India. Arch Oral Biol 2006; 51: 512-9.
18. Kulkarni DP, Wadia PP, Pradhan TN, Pathak AK, Chiplunkar SV. Mechanisms involved in the down-regulation of TCR zeta chain in tumor versus peripheral blood of oral cancer patients. Int J Cancer 2009; 124: 1605-13.
19. Angiero F, Gatta LB, Seramondi R, et al. Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer. Anticancer Res 2010; 30: 3435-40.
20. Nuovo GJ. In situ detection of human papillomavirus DNA after PCR-amplification. Methods Mol Biol 2011; 688: 35-46.
21. Scully C, Felix DH. Oral medicine: update for the dental practitioner. Oral cancer. British Dent J 2006; 200: 13-7.
22. Syrjänen S. The role of human papillomavirus infection in head and neck cancers. Ann Oncol 2010; 21(Suppl 7): vii 243-vii 245.
23. Jalouli J, Ibrahim SO, Mehrotra R, et al. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 2010; 130(11): 1306-11.
24. Gonzalez-Molez MA, Gutierrez J, Rodriguez MJ, Ruiz-Avila I, Rodriguez-Archilla A. Epstein-Barr virus latent membrane protein-1 (LMP-1) expression in oral squamous cell carcinoma. Laryngoscope 2002; 112: 482-7.
25. Nagao Y, Sata M. High incidence of multiple primary carcinomas in HCV-infected patients with oral squamous cell carcinoma. Med Sci Monit 2009; 15: CR453-9.
26. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009; 45: 317-23.
27. Garavello W, Foschi R, Talamini R, et al. Family history and the risk of oral and pharyngeal cancer. Int J Cancer 2008; 122: 1827-31.
28. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR. Genetic polymorphism of CYPIA1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 2001; 37: 593-8.
29. Li H, Chen XL, Li HQ. Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol 2005; 11: 5757-62.
30. Harty LC, Caporaso NE, Hayes RB, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 1997; 89: 1698-705.
31. Solomon PR, Selvam GS, Shanmugam G. Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians. Oral Dis 2008; 14: 633-9.
32. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-92.
33. Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Diseases 2004; 10: 212-6.
34. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168: 1-64.
35. O'Grady JF, Reade PC. Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis 1992; 13: 783-6.
36. Huang M, Spitz MR, Gu J, et al. Cyclin D1 gene polymorphism is a risk factor for oral premalignant lesions. Carcinogenesis 2006; 27: 2034-7.
37. Díez-Pérez R, Campo-Trapero J, Cano-Sánchez J, et al. Methylation in oral cancer and pre-cancerous lesions (Review). Oncol Rep 2011; 25(5): 1203-9.
38. Sidransky D. Molecular genetics of head and neck cancer. Curr Opin Oncol 1995; 7: 229-33.
39. Michailidou E, Markopoulos AK, Antoniades DZ. Mast cells and angiogenesis in oral malignant and premalignant lesions. Open Dent J 2008; 2: 120-6.
40. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implication of multicentric origin. Cancer 1953; 6: 963-8.
41. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996; 56: 2484-7.
42. Braakhuis BJ, Tabor MP, Kummer JA, Leemans R, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63:1727-30.
43. Braakhuis BJ, Leemans CR, Brakenhoff RH. A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 2004; 33: 317-22.
44. Lacy PD, Spitznagel EL, Piccirillo JF. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma. Cancer 1999; 86; 1387-95.
45. Marsh D, Suchak K, Moutasim KA, et al. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 2011; 223: 470-81.
46. de Araújo RF, Barboza Jr CA, Clebis NK, de Moura SA, Lopes Costa Ade L. Prognostic significance of the anatomical location and TNM clinical classification in oral squamous cell carcinoma. Med Oral Pathol Oral Cir Bucal 2008; 13: E344-7.
47. Hill BT, Price LA. Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate. Am J Clin Oncol 1994; 17: 1-5.
48. Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med 2010; 39: 299-305.
49. Shah JP, Gil Z. Current concepts in management of oral cancer: surgery. Oral Oncol 2009; 45: 394-401.
50. Pagedar NA, Gilbert RW. Selective neck dissection: a review of the evidence. Oral Oncol 2009; 45: 416-20.
51. Mazeron R, Tao Y, Lusinchi A, Bourhis J. Current concepts in management in head and neck cancer; radiotherapy. Oral Oncol 2009; 45: 402-8.
52. Specenier PM, Vermorken JB. Current concepts for the management of head and neck cancer: Chemotherapy. Oral Oncol 2009; 45: 409-15.
53. Hamakawa H, Nakashiro K, Sumida T, et al. Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck 2008; 30: 800-9.
54. Markopoulos AK, Michailidou EZ, Tzimagiorgis G. Salivary markers for oral cancer detection. Open Dent J 2010; 4:172-8.